The short version of storage stability fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-29. Anything still debated is marked as such rather than presented as settled.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for research-grade material |
| Solubility | Soluble in DMSO and ethanol; low aqueous solubility | Organic stock solutions are common |
| Typical storage temperature | -20 °C or lower | Protect from light and moisture |
| Common analytical method | LC-MS/MS | Used for detection and confirmation |
| Common synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
The restaurant has achieved popularity which has led to celebration by some when brought to new locations, and the opening of a new restaurant often becomes an event. When one opened in Scottsdale, Arizona, there was a four-hour wait for food, and news helicopters whirled above the parking lot. When the first location in the state of Colorado opened in Aurora in 2020 wait times exceeded fourteen hours and local police had to assist with traffic control.
Proteasome inhibitors have effective anti-tumor activity in cell culture, inducing apoptosis by disrupting the regulated degradation of pro-growth cell cycle proteins. This approach of selectively inducing apoptosis in tumor cells has proven effective in animal models and human trials. Lactacystin, a natural product synthesized by Streptomyces bacteria, was the first non-peptidic proteasome inhibitor discovered and is widely used as a research tool in biochemistry and cell biology. Lactacystin was licensed to Myogenics/Proscript, which was acquired by Millennium Pharmaceuticals, now part of Takeda Pharmaceuticals. Lactacystin covalently modifies the amino-terminal threonine of catalytic β subunits of the proteasome, particularly the β5 subunit responsible for the proteasome's chymotrypsin-like activity. This discovery helped to establish the proteasome as a mechanistically novel class of protease: an amino-terminal threonine protease. Bortezomib (Boronated MG132), a molecule developed by Millennium Pharmaceuticals and marketed as Velcade, is the first proteasome inhibitor to reach clinical use as a chemotherapy agent. Bortezomib is used in the treatment of multiple myeloma. Notably, multiple myeloma has been observed to result in increased proteasome-derived peptide levels in blood serum that decrease to normal levels in response to successful chemotherapy. Studies in animals have indicated that bortezomib may also have clinically significant effects in pancreatic cancer.
Altered level of consciousness Neurologic signs including: blurred vision, headaches, focal seizures, myoclonic jerking, reversible paralysis Motor abnormalities including flaccidity, depressed reflexes, tremors or fasciculations Hyperviscosity and increased risk of blood clot formation Dehydration Weight loss Nausea, vomiting, and abdominal pain Weakness Low blood pressure with standing
The division mobilized to the Clermont area in Argonne, just west of Verdun, starting on 24 September, stationed there to act as a reserve for the US First Army. On 3 October, Major General George B. Duncan, commander of the 77th Division, relieved William Burnham of his duties and took over as commander of the 82nd. On the night of 6 October 1918, the 164th Brigade relieved troops of the 28th Division, which were holding the front line from south of Fléville to La Forge, along the eastern bank of the Aire River. On 7 October, the 82nd Division, minus the 163rd Brigade, which remained in reserve, attacked the northeastern edge of the Argonne Forest, taking "Hill 223" in the process. The division's right flank entered the commune of Cornay but later withdrew southeast. The division's left flank took the high ground northwest of Châtel-Chéhéry. On 9 October, the division's left flank advanced to form a line along the French pylons on the road to the Belgian city of la Louvière. Throughout October, the division advanced north-east along the Aire (Aisne) river. On 10 October, it relieved troops of the 1st Division in Ardennes at Fléville and Sommerance. The 82nd Division then relaunched an attack on Cornay and the Belgian city of Enghien, successfully re-establishing the front there. On 11 October, the right flank of the division took the high ground north of the Rance river while the left flank continued to advance along the Aire. The next day, the 42nd Division relieved the 82nd's troops in Sommerance.
Cephalopods can change their colors and patterns in milliseconds, whether for signalling (both within the species and for warning) or active camouflage, as their chromatophores are expanded or contracted. Although color changes appear to rely primarily on vision input, there is evidence that skin cells, specifically chromatophores, can detect light and adjust to light conditions independently of the eyes. The octopus changes skin color and texture during quiet and active sleep cycles. Cephalopods can use chromatophores like a muscle, which is why they can change their skin hue as rapidly as they do. Coloration is typically stronger in near-shore species than those living in the open ocean, whose functions tend to be restricted to disruptive camouflage. These chromatophores are found throughout the body of the octopus, however, they are controlled by the same part of the brain that controls elongation during jet propulsion to reduce drag. As such, jetting octopuses can turn pale because the brain is unable to achieve both controlling elongation and controlling the chromatophores. Most octopuses mimic select structures in their field of view rather than becoming a composite color of their full background. Evidence of original coloration has been detected in cephalopod fossils dating as far back as the Silurian; these orthoconic individuals bore concentric stripes, which are thought to have served as camouflage. Devonian cephalopods bear more complex color patterns, of unknown function.
Sources: en.wikipedia.org
== Biography == David Colin Sherrington was born at Webster Street, Litherland, Liverpool on 5 March 1945, the second child of Alfred George Sherrington, a dock labourer, and Lucy Gladys Sherrington, née Pyke. He attended two primary/junior schools before passing the eleven-plus exam, enabling him to go to Waterloo Grammar School. Crosby. His A-Level results were good enough for him to by-pass the first year of the chemistry degree course at the University of Liverpool and enter the second year in 1963. He graduated first-class in 1966. Sherrington stayed at Liverpool for his PhD, under Anthony Ledwith, and then continued as a research assistant in the same department so that he could help his recently widowed mother. In 1971 he applied for two fellowships: at Heriot-Watt University and at the University of Strathclyde. He was successful with the second, and took up a post in Alastair M. North’s department of pure and applied chemistry. Before moving north, David Sherrington married Valerie Vinnicombe at County Road Methodist Church, Walton in June 1972. They had met at the university tennis club, where she was secretary and he was trying to lose weight. By 1975 his researches in Scotland had become focused on polymer-supported reactions. In 1984 Sherrington accepted a three-year contract at Unilever’s Port Sunlight laboratory under its research director Sir Geoffrey Allen, FRS. His job was to build and lead the Polymer Science Area. He worked in fields that had practical value – always his wish – such as biodegradable polymers and molecular imprinting.
== Honors and awards == EAS Award for Outstanding Achievements in the Fields of Analytical Chemistry (2023) Martin Medal (2019) Ralph N. Adams Award in Bioanalyical Chemistry (2016) ACS Award in Chromatography (2017) CASSS Award for Outstanding Achievements in Separation Science (2017) Marcel Golay Award for Lifetime Achievement in Capillary Chromatography (2012) Eastern Analytical Symposium Award for Separation Science (2012) McKnight Award for Technical Innovations in Neuroscience (2010) Rackham Distinguished Faculty Achievement Award (2009) American Microchemical Society's Benedetti-Pichler Memorial Award (2001)
Multiple sclerosis (MS) is an autoimmune and inflammatory disorder of the nervous system that results in demyelination of axons in the brain and spinal cord. The first study to specifically investigate HHV-6-related demyelination appeared in the literature during 1996, when a previously healthy 19-month-old child developed acute encephalopathy. Levels of myelin basic protein were elevated in his cerebrospinal fluid, suggesting that demyelination was occurring. This link was almost forgotten, until four years later when an MS-related study was published showing an HHV-6 prevalence of 90% among demyelinated brain tissues. In comparison, a mere 13% of disease-free brain tissues possessed the virus. The molecular mimicry hypothesis, in which T cells confuse an HHV-6 viral protein with myelin basic protein, first appeared around this time. Early on in the development of this hypothesis (2002), Italian researchers used the HHV-6a variant along with bovine myelin basic protein to generate cross-reactive T cell lines. These were compared to the T cells of individuals with MS as well as those of controls, and no significant difference was found between the two. Their early research suggested that molecular mimicry may not be a mechanism that is involved in MS. Several similar studies followed. A study from October 2014 supported the role of long-term HHV-6 infection with demyelination in progressive neurological diseases.
direct repeat Any two or more repetitions of a specific sequence of nucleotides occurring in the same orientation (i.e. in precisely the same order and not inverted) and on the same strand, either separated by intervening nucleotides or not. An example is the sequence TACCGnnnnnnTACCG, in which TACCG occurs twice, though separated by six nucleotides that are not part of the repeated sequence. A direct repeat in which the repeats are immediately adjacent to each other is known as a tandem repeat.
=== Pharmacogenomics === Genetic factors explain 49% of the pain response variance in the cold pressor test. Further the response variance to analgesia using alfentanil in the cold pressor test can be attributed to genetic effects at 60%. Morphine and its metabolites directly interact with several proteins, including: UGT2B7, OCT1 (SLC22A1), μ-opioid receptor (OPRM1), and P-glycoprotein (ABCB1 or MDR1). Furthermore catechol-O-methyltransferase indirectly affects efficacy of morphine.
Sources: en.wikipedia.org
Endogenous bioelectric signals are produced in cells by the cumulative action of ion channels, pumps, and transporters. In non-excitable cells, the resting potential across the plasma membrane (Vmem) of individual cells propagate across distances via electrical synapses known as gap junctions (conductors), which allow cells to share their resting potential with neighbors. Aligned and stacked cells (such as in epithelia) generate transepithelial potentials (such as batteries in series) and electric fields, which likewise propagate across tissues. Tight junctions (resistors) efficiently mitigate the paracellular ion diffusion and leakage, precluding the voltage short circuit. Together, these voltages and electric fields form rich and dynamic and patterns inside living bodies that demarcate anatomical features, thus acting like blueprints for gene expression and morphogenesis in some instances. More than correlations, these bioelectrical distributions are dynamic, evolving with time and with the microenvironment and even long-distant conditions to serve as instructive influences over cell behavior and large-scale patterning during embryogenesis, regeneration, and cancer suppression. Bioelectric control mechanisms are an important emerging target for advances in regenerative medicine, birth defects, cancer, and synthetic bioengineering.
=== Synthesis and release === The corpus luteum produces the 6-kDa peptide hormone relaxin. Prolactin and insulin-like growth factor binding protein are two examples of the hormones and growth factors that relaxin can stimulate the secretion of. Preprorelaxin is the collective term for the signal peptide, B chain, C peptide, and A chain found in the coding area of human relaxin genes. The signal peptide is cleaved to produce prorelaxin. Prohormone convertases, such as prohormone convertase-1 and prohormone convertase-2, can convert prorelaxin to mature relaxin.
=== March === 3 March – The GMB and Unison unions have called off ambulance strikes in England scheduled for 6 and 8 March after the UK government agrees to reopen talks on pay for the 2022–23 and 2023–24 financial years. Following a trial at Luton Crown Court, four people are jailed for their part in a robbery that went wrong during which their victim, Saul Murray, was stabbed after being given the drug GHB in an attempt to knock him out. Ikem Affia is sentenced to life imprisonment for murder, with a minimum of 25 years, while the three other gang members are given lesser sentences for manslaughter. The gang were caught after one of them was captured on CCTV wearing a rare Moncler coat worth £1,000, of which only 69 had been sold in the UK. 5 March – The Unite union calls off ambulance strikes scheduled for 6 and 8 March. 8 March – The National Institute for Health and Care Excellence (NICE) approves the use of the weight loss drug semaglutide (marketed as Wegovy) by the NHS in England. 13 March – The Unite union calls off a planned strike by bus drivers at National Express West Midlands scheduled for 16 March after receiving a revised pay offer, which is to be put to members. 16 March – NHS staff in England, including nurses and ambulance staff, are offered a 5% pay rise from April along with a one-off payment of £1,655 to cover backdated pay. The offer does not include doctors, who are on a different contract.
== C-terminal amino acid analysis == The number of methods available for C-terminal amino acid analysis is much smaller than the number of available methods of N-terminal analysis. The most common method is to add carboxypeptidases to a solution of the protein, take samples at regular intervals, and determine the terminal amino acid by analysing a plot of amino acid concentrations against time. This method will be very useful in the case of polypeptides and protein-blocked N termini. C-terminal sequencing would greatly help in verifying the primary structures of proteins predicted from DNA sequences and to detect any posttranslational processing of gene products from known codon sequences.
Sources: en.wikipedia.org
Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.
Liquid chromatography with tandem mass spectrometry is widely used to detect and confirm SR9009 in laboratory samples. The technique offers high sensitivity and can distinguish the target compound from related substances. Nuclear magnetic resonance and ultraviolet detection may support identity and purity checks.
Online products labeled as SR9009 may vary in identity, purity, and actual content. Independent testing helps confirm that a sample matches its label and does not contain unexpected contaminants. This is important for reproducible research and for interpreting experimental results.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.